Cargando…

Cellular mechanism of action of forsythiaside for the treatment of diabetic kidney disease

Background: Diabetic kidney disease (DKD) becomes the leading cause of death for end-stage renal disease, whereas the potential mechanism is unclear and effective therapy is still rare. Our study was designed to investigate the cellular mechanism of Forsythiaside against DKD. Materials and Methods:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Chunmei, Miao, Huikai, Chen, Xiaoxuan, Zhang, Haiqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880420/ https://www.ncbi.nlm.nih.gov/pubmed/36712665 http://dx.doi.org/10.3389/fphar.2022.1096536

Ejemplares similares

Forsythiasides-Rich Extract From Forsythiae Fructus Inhibits Mast Cell Degranulation by Enhancing Mitochondrial Ca(2+) Uptake
por: Qi, Ruijuan, et al.
Publicado: (2021)

Forsythiasides: A review of the pharmacological effects
por: Yang, Hong-Xuan, et al.
Publicado: (2022)

Exploration of anti-inflammatory mechanism of forsythiaside A and forsythiaside B in CuSO(4)-induced inflammation in zebrafish by metabolomic and proteomic analyses
por: Gong, Lihong, et al.
Publicado: (2020)

Forsythiaside B ameliorates coagulopathies in a rat model of sepsis through inhibition of the formation of PAD4-dependent neutrophil extracellular traps
por: He, Wenju, et al.
Publicado: (2022)

Impact of Azithromycin on Forsythiaside Pharmacokinetics in Rats: A Population Modeling Method
por: Tian, Jing-chen, et al.
Publicado: (2022)

Mechanism of Cordyceps sinensis and its Extracts in the Treatment of Diabetic Kidney Disease: A Review
por: Liu, Wu, et al.
Publicado: (2022)

The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease
por: Zhang, Qing, et al.
Publicado: (2021)

Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease
por: Lichnog, Charlotte, et al.
Publicado: (2019)

Forsythiaside A ameliorates sepsis-induced acute kidney injury via anti-inflammation and antiapoptotic effects by regulating endoplasmic reticulum stress
por: Chen, Yi, et al.
Publicado: (2023)

Using network pharmacology to explore the mechanism of Danggui-Shaoyao-San in the treatment of diabetic kidney disease
por: Yang, Jinfei, et al.
Publicado: (2022)

Herbal Medicine in the Treatment of Non-Alcoholic Fatty Liver Diseases-Efficacy, Action Mechanism, and Clinical Application
por: Xu, Yu, et al.
Publicado: (2020)

Cellular and Molecular Targets of Menthol Actions
por: Oz, Murat, et al.
Publicado: (2017)

The protective mechanism of Dehydromiltirone in diabetic kidney disease is revealed through network pharmacology and experimental validation
por: Wang, Yanzhe, et al.
Publicado: (2023)

Therapeutic mechanism and clinical application of Chinese herbal medicine against diabetic kidney disease
por: Chen, Dan-Qian, et al.
Publicado: (2022)

Network Pharmacology Studies on the Bioactive Compounds and Action Mechanisms of Natural Products for the Treatment of Diabetes Mellitus: A Review
por: Li, Weiwei, et al.
Publicado: (2017)

Traditional Chinese Medicine in the Treatment of Chronic Kidney Diseases: Theories, Applications, and Mechanisms
por: Wang, Yunlai, et al.
Publicado: (2022)

Bioanalytical Method Development Using Liquid Chromatography with Amperometric Detection for the Pharmacokinetic Evaluation of Forsythiaside in Rats
por: Wu, Yu-Tse, et al.
Publicado: (2016)

Forsythiaside A Regulates Activation of Hepatic Stellate Cells by Inhibiting NOX4-Dependent ROS
por: Zhou, Mengting, et al.
Publicado: (2022)

Study of the Mechanism of Action of Guanxin Shutong Capsules in the Treatment of Coronary Heart Disease Based on Metabolomics
por: Wang, Dan, et al.
Publicado: (2021)

Editorial: Combating Diabetes and Diabetic Kidney Disease
por: Srivastava, Swayam Prakash, et al.
Publicado: (2021)

Systems Pharmacology Dissection of Multi-Scale Mechanisms of Action of Huo-Xiang-Zheng-Qi Formula for the Treatment of Gastrointestinal Diseases
por: Zhao, Miaoqing, et al.
Publicado: (2019)

GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms
por: Kawanami, Daiji, et al.
Publicado: (2020)

Editorial: Diabetic kidney disease: routes to drug development, pharmacology and underlying molecular mechanisms
por: Bhatia, Divya, et al.
Publicado: (2023)

Molecular Mechanisms of Action of Emodin: As an Anti-Cardiovascular Disease Drug
por: Li, Qianqian, et al.
Publicado: (2020)

Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies
por: Xu, Jie, et al.
Publicado: (2020)

Caveolin-1 Regulates Cellular Metabolism: A Potential Therapeutic Target in Kidney Disease
por: Luo, Shilu, et al.
Publicado: (2021)

Systems Pharmacology for Investigation of the Mechanisms of Action of Traditional Chinese Medicine in Drug Discovery
por: Zhang, Wenjuan, et al.
Publicado: (2019)

Exploring the Critical Components and Therapeutic Mechanisms of Perilla frutescens L. in the Treatment of Chronic Kidney Disease via Network Pharmacology
por: Yong, Chen, et al.
Publicado: (2021)

The interaction between cellular senescence and chronic kidney disease as a therapeutic opportunity
por: Zhao, Jing-Li, et al.
Publicado: (2022)

Chinese Herbal Medicine on Cardiovascular Diseases and the Mechanisms of Action
por: Liu, Cuiqing, et al.
Publicado: (2016)

FGF, Mechanism of Action, Role in Parkinson’s Disease, and Therapeutics
por: Liu, Yiqiu, et al.
Publicado: (2021)

Forsythiaside A improves Influenza A virus infection through TLR7 signaling pathway in the lungs of mice
por: Zheng, Xiao, et al.
Publicado: (2022)

Intravitreal vascular endothelial growth factor inhibitors did not increase the risk of end-stage renal disease in patients with biopsy-proven diabetic kidney disease based on matched study
por: Xiao, Xiang, et al.
Publicado: (2022)

Nephroprotective Effects of Tetramethylpyrazine Nitrone TBN in Diabetic Kidney Disease
por: Jing, Mei, et al.
Publicado: (2021)

Multi-omics analysis reveals the pathogenesis of db/db mice diabetic kidney disease and the treatment mechanisms of multi-bioactive compounds combination from Salvia miltiorrhiza
por: Xu, Zhuo, et al.
Publicado: (2022)

Network meta-analysis of mineralocorticoid receptor antagonists for diabetic kidney disease
por: Wu, Yichuan, et al.
Publicado: (2022)

Molecular mechanisms and physiological functions of autophagy in kidney diseases
por: Yang, Jingchao, et al.
Publicado: (2022)

Mechanism of Tripterygium wilfordii Hook.F.- Trichosanthes kirilowii Maxim decoction in treatment of diabetic kidney disease based on network pharmacology and molecular docking
por: Lu, Lingfei, et al.
Publicado: (2022)

Effect of Forsythiaside A on the RLRs Signaling Pathway in the Lungs of Mice Infected with the Influenza A Virus FM1 Strain
por: Zheng, Xiao, et al.
Publicado: (2019)

Integrating Network Pharmacology and Metabolomics to Elucidate the Mechanism of Action of Huang Qin Decoction for Treament of Diabetic Liver Injury
por: Xu, Xiaomin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0iiivb89hpg7ti6nqicr210nrh